tigenix.com
. TiGenix NV is an advanced biopharmaceutical company focused on developing and commercializing novel therapeutics from its proprietary platforms of allogeneic, or donor-derived, expanded stem cells.
Listed on Euronext
(Belgium): TIG
Exited
Location: Belgium, Flemish Brabant, Leuven
Employees: 51-200
Total raised: $15.07M
Founded date: 2000
Investors 2
Date | Name | Website |
- | Auriga Par... | auriga.vc |
- | KU Leuven ... | lrd.kuleuv... |
Funding Rounds 2
Date | Series | Amount | Investors |
27.12.2011 | Grant | $3.79M | - |
14.12.2009 | - | $11.28M | - |
Mentions in press and media 16
Date | Title | Description | Source |
24.03.2018 | TiGenix and Takeda announce Alofisel® (darvadstrocel) receiv... | TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) and Takeda Pharmaceutical Company Limited... | 4biocapita... |
05.01.2018 | Takeda announces its intention to acquire TiGenix | TiGenix NV ("TiGenix") (Euronext Brussels and NASDAQ: "TIG"), an advanced biopha... | 4biocapita... |
15.12.2016 | TiGenix, participada por Ysios, obtiene $35,65M con la ofert... | 15/12/2016 TIGENIX, PARTICIPADA POR YSIOS, OBTIENE $35,65 MILLONES CON LA OFERTA PÚBLICA EN EL NASD... | webcapital... |
07.12.2016 | Tigenix, participada por Ysios Capital, anuncia su salto al ... | 07/12/2016 TIGENIX, PARTICIPADA POR YSIOS CAPITAL, ANUNCIA SU SALTO AL NASDAQ. TiGenix NV, partici... | webcapital... |
06.12.2016 | TiGenix files for $43M IPO to fund stem cell therapy phase 3 | TiGenix has taken another step toward its delayed Nasdaq IPO. The stem cell therapy specialist is ai... | fiercebiot... |
09.01.2012 | TiGenix reports positive results of ChondroCelect® compassio... | TiGenix reports positive results of ChondroCelect® compassionate use program 09-01-2012 TiGenix, a... | cambridgen... |
27.12.2011 | TiGenix obtains EUR 2.9 million FP7 grant to fund developmen... | TiGenix obtains EUR 2.9 million FP7 grant to fund development of Cx611 in rheumatoid arthr... 27-12... | cambridgen... |
23.12.2011 | TiGenix obtiene una subvención de €2,9 millones del Séptimo ... | 23/12/2011 Nota de Prensa TIGENIX OBTIENE UNA SUBVENCIÓN DE €2,9 MILLONES DEL SÉPTIMO PROGRAMA MAR... | webcapital... |
21.12.2011 | TiGenix receives green light to start Phase I with Cx621 | TiGenix receives green light to start Phase I with Cx621 21-12-2011 TiGenix (NYSE Euronext: TIG) a... | cambridgen... |
10.11.2010 | TiGenix completes second phase of the Orthomimetics acquisit... | TiGenix completes second phase of the Orthomimetics acquisition 10-11-2010 TiGenix announces that ... | cambridgen... |
Show more